$BMRN Headlines BioMarin shares rally as FDA mutes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BMRN Headlines

BioMarin shares rally as FDA mutes criticism of rare disorder drug 5:25 p.m. Nov. 15, 2013 - Russ Britt
German DAX ends at record as Europe stocks rally 11:10 a.m. Sept. 19, 2013 - Sara Sjolin
BioMarin rallies 7.6% on Roche takeover report 5:30 a.m. Sept. 19, 2013 - Sara Sjolin
S&P 500 retests the 50-day moving average 10:07 a.m. Sept. 9, 2013 - Michael Ashbaugh
Biotech ETF's breakout: bullish for stocks overall? 12:11 p.m. Sept. 5, 2013 - blogs.marketwatch.com
Acura, BioMarin mount independent rallies on their own positive news 2:28 p.m. July 1, 2013 - Russ Britt
After the close: Biogen slips, Epizyme slows, BioMarin stalls 4:57 p.m. June 4, 2013 - Russ Britt
Lofty expectations hit BioMarin in development of new cancer drugs 11:56 a.m. June 3, 2013 - Russ Britt
Get out of junk stocks now 12:14 p.m. March 22, 2013 - Mark Hulbert
Charting a slow-motion test of the 2012 peak 11:39 a.m. Jan. 11, 2013 - Michael Ashbaugh
U.S. benchmarks sustain the 2013 breakout 12:00 p.m. Jan. 4, 2013 - Michael Ashbaugh
Meet the S&P 500’s new range 11:17 a.m. Dec. 13, 2012 - Michael Ashbaugh
Charting a lackluster recovery attempt 11:49 a.m. Nov. 21, 2012 - Michael Ashbaugh
‘Aggressive’ comment hits Express Scripts 6:03 p.m. Nov. 5, 2012 - Russ Britt
BioMarin's GALNS meets primary endpoint in trial 9:24 a.m. Nov. 5, 2012 - MarketWatch.com
Biomarin says trial results meet primary endpoint 7:23 a.m. Nov. 5, 2012 - Greg Morcroft
Biomarin says its GALNS Phase III trial posiitve 7:23 a.m. Nov. 5, 2012 - Greg Morcroft
Staking out major support 9:46 a.m. Oct. 3, 2012 - Michael Ashbaugh
Corrective bounce, or sustainable upturn? 10:51 a.m. July 13, 2012 - Michael Ashbaugh
Bears come to life on jobs report 9:14 a.m. July 6, 2012 - Michael Ashbaugh


Insider Trading Alert - GNW, WFC, LII, WDR And BMRN Traded By Insiders 10:30 a.m. Dec. 12, 2013 - TheStreet.com
Orphan Drug Designations: Why You Should Care 10:23 a.m. Dec. 12, 2013 - Seeking Alpha
Myriad, Janssen Partner on BRACAnalysis - Analyst Blog 6:26 p.m. Dec. 10, 2013 - Zacks.com
Cramer's Lightning Round - The Quintessential American Stock That Is Going To Work (12/9/13) 6:01 a.m. Dec. 10, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Get Serious on Sirius 6:00 a.m. Dec. 10, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: The Rally Rules 8:20 p.m. Dec. 9, 2013 - TheStreet.com
BioMarin Seeks Canadian Approval - Analyst Blog 11:50 a.m. Dec. 5, 2013 - Zacks.com
BioMarin Submits VIMIZIM(TM) (elosulfase alfa) NDS to Health Canada for the Treatment of Morquio A Syndrome Under Priority Review Status 8:00 a.m. Dec. 4, 2013 - CNW Group
BioMarin Pharmaceutical's Management Presents at 2013 Deutsche Bank BioFEST Conference (Transcript) 2:20 p.m. Dec. 3, 2013 - Seeking Alpha
Galena: A Pipeline Rich For Investors 2:46 a.m. Dec. 2, 2013 - Seeking Alpha
Biomarin Pharmaceutical Inc. Stock Upgraded (BMRN) 10:12 a.m. Nov. 29, 2013 - TheStreet.com
UPDATE: Piper Jaffray Initiates Coverage on BioMarin Pharmaceutical on Expected Attractive Returns 10:10 a.m. Nov. 27, 2013 - benzinga.com
Biotech Stock Roundup: EU News Boosts Biogen, Gilead & Celgene - Analyst Blog 10:01 a.m. Nov. 27, 2013 - Zacks.com
2014 FDA Drug Approval Decision Calendar 8:00 a.m. Nov. 27, 2013 - TheStreet.com
UPDATE: Piper Jaffray Initiates On BioMarin Pharmaceuticals On BMN-111 Outlook 6:50 a.m. Nov. 27, 2013 - benzinga.com
Myriad, BioMarin Collaborate Again - Analyst Blog 5:05 p.m. Nov. 22, 2013 - Zacks.com
Amicus' 'Transformative" Changes Look More Like Big Step Backward 7:37 p.m. Nov. 20, 2013 - TheStreet.com
Jim Cramer's 6 Stocks in 60 Seconds: DKS COG WDAY BMRN DWRE TSLA (Update 1) 5:09 p.m. Nov. 20, 2013 - TheStreet.com
BioMarin Pharmaceutical Larger Than S&P 500 Component Linear Technology 4:44 p.m. Nov. 20, 2013 - TheStreet.com
Analysts: BioMarin Will Trade Up on Panel Vote and 3 More Research Notes to Browse 3:02 p.m. Nov. 20, 2013 - Wall St. Cheat Sheet


Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc. 10:19 a.m. Dec. 11, 2013 - PR Newswire
Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Dec. 4, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 8:00 a.m. Dec. 3, 2013 - PR Newswire
Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics 8:00 a.m. Nov. 26, 2013 - PR Newswire
Dan Spiegelman, CFO of BioMarin, to Present at the Deutsche Bank 2013 BioFest Conference in Boston 5:10 a.m. Nov. 26, 2013 - GlobeNewswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar 8:00 a.m. Nov. 20, 2013 - PR Newswire
FDA Advisory Committee Recommends Approval for BioMarin's Vimizim(TM) for the Treatment of Patients With Morquio A Syndrome 5:02 p.m. Nov. 19, 2013 - GlobeNewswire
BioMarin Stock Trading Halted Today 7:10 a.m. Nov. 19, 2013 - GlobeNewswire
FDA Posts Briefing Documents for Advisory Committee Meeting Reviewing Vimizim(TM) for the Treatment of Morquio A Syndrome 9:15 a.m. Nov. 15, 2013 - GlobeNewswire
Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
BioMarin Announces French ATU Granted for Vimizim(TM) for the Treatment of Morquio A Syndrome 7:59 a.m. Nov. 15, 2013 - GlobeNewswire
Clinical Trial Initiations, Conferences Participations, Strategic Collaborations, and Presentation of New Pre-Clinical Data - Research Report on Biogen Idec, BioMarin, Medivation, Cytori, and Alnylam 8:00 a.m. Nov. 8, 2013 - PR Newswire
Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Credit Suisse 2013 Healthcare Conference 8:30 a.m. Nov. 5, 2013 - GlobeNewswire
Critical Alerts For Citigroup, Community Health, Oracle, Boeing, and BioMarin Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 1, 2013 - PR Newswire
Biotech Companies Report Quarterly Results - Research Report on Biogen Idec, Alexion, Medivation, BioMarin, and Dyax 9:00 a.m. Oct. 31, 2013 - PR Newswire
BioMarin Initiates Phase 3 Trial for BMN 673 for the Treatment of Metastatic gBRCA Breast Cancer 5:00 a.m. Oct. 31, 2013 - GlobeNewswire
Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc. 11:34 a.m. Oct. 25, 2013 - PR Newswire
BioMarin Announces Third Quarter 2013 Financial Results 5:33 p.m. Oct. 24, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 28

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 57

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Jeff Stern Turns Travel Photography Into a Sensory Memoir

Updated Category News Views 68

Frost in a mountain tent, fermented mare’s milk in a yurt, and coffee in Vietnamese rice paddies are doing more work here than a thousand polished sunset captions ever could. Jeff Stern’s A Change of Scenery, released by Palmetto Publishing on November 17, 2026, comes from a man who spent more than 25 years building brands and then decided the usual labels around...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 77

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
Scientific Games Takes Big Buck Hunter to Lotteries

Updated Category News Views 84

A mounted arcade cabinet is an odd place to find lottery growth, yet Scientific Games may be onto something with its exclusive Big Buck Hunter licensing deal. Announced November 19, 2026, the arrangement lets the company carry a 26-year-old arcade franchise into U.S. and Canadian instant scratch games, Fast Play, draw games, digital products and second-chance promotions....

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 50

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 133

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 89

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 107

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from BioRestorative's CEO on Regenerative Medicine

Updated Category News Views 168

CEO Lance Alstodt Discusses BioRestorative's Vision In a recent interview on “The Big Biz Show,” the dynamic CEO of BioRestorative Therapies, Inc., Lance Alstodt, shared invaluable insights into the company's journey. As a pioneer in regenerative medicine, BioRestorative focuses on innovative stem cell-based therapies aimed at addressing various medical challenges....

Continue Reading
Hargreave Hale AIM VCT PLC NAV Announcement

Updated Category News Views 73

Hargreave Hale AIM VCT PLC (the “Company”) Net Asset Value Announcement As of the close of business on 16 August 2024, the unaudited Net Asset Value (NAV) for Hargreave Hale AIM VCT plc stands at: NAV per Ordinary share of 1p – 42.03 pence. Contact Information If you need more information, please reach out to: JTC (UK) Limited Uloma Adighibe Alexandria Tivey Email...

Continue Reading
Discover Luxury Living at Toll Brothers' New Community in Texas

Updated Category News Views 150

Introducing Toll Brothers at George's Ranch In a splendid showcase of luxury living, Toll Brothers, Inc. (NYSE:TOL) has unveiled its newest community, Toll Brothers at George's Ranch, located in the serene surroundings of Boerne, Texas. This exciting development marks an important addition to the San Antonio area, where elegance meets modern design. Grand Opening...

Continue Reading
xLean's TR1 Robot Revolutionizes Cleaning Technology

Updated Category News Views 224

xLean's Innovative TR1 Takes Center Stage xLean Robotics concluded an exciting showcase at IFA 2025, where its groundbreaking TR1, the world's first dual-form transformable floor washing robot, earned several prestigious awards. This innovative device was recognized as the 'Best in IFA Next Winner' and 'Best in Design Honoree,' and it was featured as one of the 'Top 5...

Continue Reading
Alpha Modus Sues H&M for Patent Infringement Regarding AI Tech

Updated Category News Views 165

Alpha Modus Files Patent Infringement Lawsuit Against H&M Alpha Modus, Corp. is making headlines for filing a substantial patent infringement lawsuit against H&M Fashion USA, Inc. in the United States District Court for the Eastern District of Texas, Marshall Division. This legal action centers around allegations that H&M's retail operations in the U.S. are infringing...

Continue Reading